FDA approves first nonprescription daily oral contraceptive
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA announces additional steps to modernize clinical trials
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first drug to treat agitation symptoms associated with dementia due to Alzheimer's disease
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first respiratory syncytial virus (RSV) vaccine
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first over-the-counter naloxone nasal spray
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA grants Accelerated Approval for Alzheimer's disease treatment
- FDA approves new HIV drug for adults with limited treatment options
- FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
- FDA approves first gene therapy to treat adults with Hemophilia B
- FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
- FDA approves first systemic treatment for alopecia areata
- FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain